chr1-145974894-G-A

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_032305.3(POLR3GL):​c.29G>A​(p.Arg10His) variant causes a missense change. The variant allele was found at a frequency of 0.00019 in 1,518,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

POLR3GL
NM_032305.3 missense

Scores

2
5
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.79

Publications

3 publications found
Variant links:
Genes affected
POLR3GL (HGNC:28466): (RNA polymerase III subunit GL) Predicted to enable chromatin binding activity. Involved in transcription by RNA polymerase III. Located in nucleus. Part of RNA polymerase III complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3638371).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POLR3GLNM_032305.3 linkc.29G>A p.Arg10His missense_variant Exon 2 of 8 ENST00000369314.2 NP_115681.1 Q9BT43
POLR3GLNM_001330685.2 linkc.29G>A p.Arg10His missense_variant Exon 2 of 7 NP_001317614.1 Q9BT43A6NGX6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POLR3GLENST00000369314.2 linkc.29G>A p.Arg10His missense_variant Exon 2 of 8 1 NM_032305.3 ENSP00000358320.1 Q9BT43
ENSG00000280778ENST00000625258.1 linkc.-29-2190G>A intron_variant Intron 1 of 3 5 ENSP00000487094.1 A0A0D9SG24

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152120
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000154
AC:
24
AN:
156130
AF XY:
0.000115
show subpopulations
Gnomad AFR exome
AF:
0.000108
Gnomad AMR exome
AF:
0.000877
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000126
Gnomad OTH exome
AF:
0.000615
GnomAD4 exome
AF:
0.000200
AC:
274
AN:
1366610
Hom.:
0
Cov.:
31
AF XY:
0.000164
AC XY:
111
AN XY:
675686
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27828
American (AMR)
AF:
0.000712
AC:
16
AN:
22464
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22940
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33614
South Asian (SAS)
AF:
0.0000141
AC:
1
AN:
70894
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51950
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5496
European-Non Finnish (NFE)
AF:
0.000231
AC:
248
AN:
1075238
Other (OTH)
AF:
0.000160
AC:
9
AN:
56186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152238
Hom.:
0
Cov.:
32
AF XY:
0.0000537
AC XY:
4
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41550
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68004
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000168
Hom.:
0
Bravo
AF:
0.0000869

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 15, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.29G>A (p.R10H) alteration is located in exon 2 (coding exon 1) of the POLR3GL gene. This alteration results from a G to A substitution at nucleotide position 29, causing the arginine (R) at amino acid position 10 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_noAF
Pathogenic
0.59
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.35
T;T
LIST_S2
Uncertain
0.87
D;D
MetaRNN
Benign
0.36
T;T
PhyloP100
6.8
PROVEAN
Uncertain
-4.0
D;D
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.015
D;D
Vest4
0.35
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370170498; hg19: chr1-145460194; COSMIC: COSV65215688; API